Anhui Progression Biotechnology Co., Ltd. is located in the Economic and Technological Development Zone of Lu'an City, Anhui Province. The project covers an area of nearly 7 hectares. The main project includes the guard room, restaurant, comprehensive building, office building, staff dormitory, production plant, central warehouse, etc., with a total investment of about 1 billion yuan.

It will introduce 15 automatic production lines imported from Germany, build four major technology research and development centers, and become the largest professional industrial park in China's chronic disease detection technology industry. After the completion of the project, the estimated annual output value is 2 billion yuan, and it will become the largest professional industrial park in China's chronic disease detection technology industry. The project is expected to solve 1500 local jobs in Lu'an, and the total annual tax payment is expected to be about 40 million yuan after the project is officially put into operation.

Lu'an has a profound historical background, unique geographical advantages and a good business environment. The completed industrial park is about 40-50 minutes away from Hefei Xinqiao International Airport, about 1 hour away from Wuhan High-speed Railway, and about 1 hour away from Nanjing High-speed Railway. The construction of the “Hefei-Lu'an Economic Corridor” will continue to drive the further development of Anhui Progression Biotechnology Co., Ltd.

Minkang is a national high-tech enterprise committed to the research, development, production and sales of rapid detection products for chronic diseases using biological sensing technology. At present, it has formed four leading domestic technical systems of electrochemistry, photochemistry, colloidal gold and immunity, and has obtained more than 50 patents and software copyrights. The whole series of products cover the detection of multiple indicators such as blood glucose, blood lipids, blood ketone, uric acid, glycosylated hemoglobin, and rapidly upgrade according to the development path of blood glucose detection - multiple indicators detection - intelligent detection, to create an ecological closed-loop of chronic disease management from monitoring to data analysis to the implementation of diagnosis and treatment programs.

The completion of Anhui Progression Biotechnology Co., Ltd. will greatly improve the scientific research and production strength of Minkang in the field of chronic disease management. At the same time, Minkang will actively promote relevant industrial cooperation, seek a new path for regional development, and strive to build a comprehensive, multi-dimensional and full-industrial chain strategic cooperation relationship in line with the "14th Five-Year Plan" of Lu'an City and the principle of "Work Together and Benefit Each Other ".